Tag: <span>mRNA cancer vaccine</span>

Home / mRNA cancer vaccine
Post

4 Things to Know About Moderna’s mRNA Cancer Vaccine

Patricia McKnight December 16, 2022 A cancer vaccine based on the messenger RNA (mRNA) technology, provided alongside the checkpoint inhibitor pembrolizumab (Keytruda), has shown encouraging results in an open label phase 2b clinical trial. The trial found that the combination regimen reduced the risk of cancer recurrence or death among melanoma patients by 44% compared with pembrolizumab alone, according to the vaccine’s...

Moderna says personalized mRNA cancer vaccine is effective for advanced melanoma
Post

Moderna says personalized mRNA cancer vaccine is effective for advanced melanoma

The company said that in a phase 2 clinical trial, the vaccine, when combined with immunotherapy drug Keytruda, reduced the risk of recurrence by 44%. A Moderna building in Cambridge, Mass., on May 18, 2020.Bill Sikes / AP fileLink copied Dec. 13, 2022, 10:13 AM MSTBy The Associated Press Moderna’s stock soared Tuesday after the Covid-19...